Advertisement

Prevalence of axial spondyloarthritis in Poland

  • Małgorzata TłustochowiczEmail author
  • Melania Brzozowska
  • Waldemar Wierzba
  • Filip Raciborski
  • Brygida Kwiatkowska
  • Witold Tłustochowicz
  • Andrzej Jacyna
  • Michał Marczak
  • Bartłomiej Kisiel
  • Andrzej Śliwczyński
Epidemiology of RMD
  • 28 Downloads

Abstract

The prevalence of axial spondyloarthritis (axSpA) in the published data varies significantly. Two types of axSpA can be distinguished depending upon the presence of abnormalities consistent with sacroiliitis on plain radiography: ankylosing spondylitis (AS) and nonradiographic axial SpA (nr-axSpA). The aim of this study is to perform a retrospective analysis of axSpA prevalence in Poland in the years 2008–2017. The National Health Fund (NHF) database for the period 2008–2017 was analysed. Data of all patients with the ICD-10 codes M46 (M46.1, M46.8, M46.9) or M45 (further named other inflammatory spondylopathies—OIS and AS, respectively) as the main or co-existing diagnosis were extracted and analysed. The AS prevalence was stable during the period under examination amounting to approximately 0.083%, while the OIS prevalence increased from 0.036 to 0.059%. For both men and women, the AS prevalence increased with age, reaching a maximum around the age of 70; however, in men, a marked increase in prevalence was observed earlier as compared to women (20–24 vs. 40–44 years, respectively). The OIS prevalence also increased with age; however, the maximum was reached earlier as in case of AS. Moreover, a sharp increase in OIS prevalence occurred earlier than in AS (15–19 years) with no difference between sexes. In Poland, approximately 0.1% of the population suffers from AS—the prevalence remained stable over the last decade. The prevalence of OIS increased markedly over the studied period which presumably reflects an increasing prevalence of nr-axSpA as the effect of the introduction of ASAS classification criteria for axSpA.

Keywords

Ankylosing spondylitis Spondyloarthritis Epidemiology Prevalence 

Notes

Author contributions

MT: conception and design of the work; analysis and interpretation of data for the work; drafting the manuscript; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. MB: conception and design of the work; acquisition and analysis of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. WW: conception and design of the work; interpretation of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. FR: conception and design of the work; interpretation of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. BrK: conception and design of the work; interpretation of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. WT: conception and design of the work; interpretation of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. AJ: conception and design of the work; interpretation of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. MM: conception and design of the work; interpretation of data for the work; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. BaK: conception and design of the work; analysis and interpretation of data for the work; drafting the manuscript; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. AS: conception and design of the work; acquisition, analysis and interpretation of data for the work; drafting the manuscript; final approval of the version to be published; agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Funding

None.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

For this study, ethical approval is not required.

Informed consent

Patients’ written informed consent was not needed, as this was a retrospective type of study.

References

  1. 1.
    van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostics criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368CrossRefGoogle Scholar
  2. 2.
    Dubreuil M, Sieper J (2018) Inflammatory back pain and axial spondyloarthritis: lessons for clinical practice and epidemiologic research. Arthritis Rheumatol 70:981–983.  https://doi.org/10.1002/art.40462 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, Dougados M, Hermann KG, Landewé R, Maksymowych W, van der Heijde D (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–44.  https://doi.org/10.1136/ard.2008.104018 CrossRefPubMedGoogle Scholar
  4. 4.
    Mathieu A, Paladini F, Vacca A, Cauli A, Fiorillo MT, Sorrentino R (2009) The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev 8:420–425.  https://doi.org/10.1016/j.autrev.2009.01.003 CrossRefPubMedGoogle Scholar
  5. 5.
    Khan MA (1998) Spondyloarthropathies. Curr Opin Rheumatol. 10(4):279–281CrossRefGoogle Scholar
  6. 6.
    Bakland G, Nossent HC (2013) Epidemiology of spondyloarthritis: a review. Curr Rheumatol Rep 15:351.  https://doi.org/10.1007/s11926-013-0351-1 CrossRefPubMedGoogle Scholar
  7. 7.
    Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ (2014) Global prevalence of ankylosing spondylitis. Rheumatology (Oxford) 53:650–657.  https://doi.org/10.1093/rheumatology/ket387 CrossRefGoogle Scholar
  8. 8.
    Reveille JD, Weisman MH (2013) The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States. Am J Med Sci 345:431–436.  https://doi.org/10.1097/maj.0b013e318294457f CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Śliwczyński A, Raciborski F, Kłak A, Brzozowska M, Czeleko T, Kwiatkowska B, Jędrzejczyk T, Marczak M (2015) Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public health care system. Rheumatol Int 35:1361–1367.  https://doi.org/10.1007/s00296-015-3247-8 CrossRefPubMedGoogle Scholar
  10. 10.
  11. 11.
  12. 12.
    Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61(Suppl III):iii8–iii18CrossRefGoogle Scholar
  13. 13.
    Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, Maksymowych WP (2011) Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 63:3294–3304.  https://doi.org/10.1002/art.30581 CrossRefPubMedGoogle Scholar
  14. 14.
    Haroon NN, Paterson JM, Li P, Haroon N (2014) Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS. BMJ Open 4:e006634.  https://doi.org/10.1136/bmjopen-2014-006634 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Singh JA, Holmgren AR, Krug H, Noorbaloochi S (2007) Accuracy of the diagnoses of spondyloarthritis in veterans affairs medical center databases. Arthritis Rheum 57:648–655CrossRefGoogle Scholar
  16. 16.
  17. 17.
    Lee W, Reveille JD, Weisman MH (2008) Women with ankylosing spondylitis: a review. Arthritis Rheum 59:449–454.  https://doi.org/10.1002/art.23321 CrossRefPubMedGoogle Scholar
  18. 18.
    Baumberger H, Khan M (2017) Gradual progressive change to equal prevalence of ankylosing spondylitis among males and females in Switzerland: data from the Swiss Ankylosing Spondylitis Society (SVMB) [abstract]. Ann Rheum Dis.  https://doi.org/10.1136/annrheumdis-2017-eular.3961 CrossRefGoogle Scholar
  19. 19.
    Rusman T, van Vollenhoven RF, van der Horst-Bruinsma IE (2018) Gender differences in axial spondyloarthritis: women are not so lucky. Curr Rheumatol Rep 20:35.  https://doi.org/10.1007/s11926-018-0744-2 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Slobodin G, Reyhan I, Avshovich N, Balbir-Gurman A, Boulman N, Elias M, Feld J, Mader R, Markovitz D, Rimar D, Rosner I, Rozenbaum M, Zisman D, Odeh M (2011) Recently diagnosed axial spondyloarthritis: gender differences and factors related to delay in diagnosis. Clin Rheumatol 30:1075–1080.  https://doi.org/10.1007/s10067-011-1719-0 CrossRefPubMedGoogle Scholar
  21. 21.
    Montilla C, Diaz-Alvarez A, Calero-Paniagua I, Collantes-Estevez E, Font P, Almodovar R, Zarco P, Queiro-Silva R, Canete JD, Juanola X, Mulero J, de Miguel E, Gratacos J, on behalf of the REGISPONSER Study Group (2014) Ankylosing spondylitis without axial progression: analysis of associated factors. J Rheumatol 41:2409–2412.  https://doi.org/10.3899/jrheum.140018 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Internal Diseases and RheumatologyMilitary Institute of MedicineWarszawaPoland
  2. 2.Department of Management and Logistics in Health CareMedical University in LodzŁódźPoland
  3. 3.Department of Drug ManagementNational Health FundWarszawaPoland
  4. 4.Satellite Campus in WarsawUniversity of Humanities and Economics in LodzŁódźPoland
  5. 5.Department of Prevention of Environmental Hazards and AllergologyMedical University of WarsawWarszawaPoland
  6. 6.Early Arthritis ClinicNational Institute of Geriatrics, Rheumatology and RehabilitationWarszawaPoland
  7. 7.National Health FundWarszawaPoland
  8. 8.Department of Healthcare ServicesNational Health FundWarszawaPoland

Personalised recommendations